TABLE 1.

The characteristics of COVID‐19 patients who have developed dermatologic diseases

Number	Age	Gender	Diagnosis	The time duration for diagnosis after COVID‐19
1	57	Male	Herpes zoster	4 weeks
2	42	Female	Herpes zoster	18 weeks
3	36	Male	Herpes zoster	14 weeks
4	61	Female	Herpes zoster	12 weeks
5	62	Male	Herpes zoster	16 weeks
6	38	Female	Herpes zoster	3 weeks
7	43	Female	Herpes zoster	11 weeks
8	49	Male	Herpes zoster	8 weeks
9	26	Female	Pityriasis rosea	1 week
10	29	Female	Pityriasis rosea	2 weeks
11	19	Male	Pityriasis rosea	4 weeks
12	17	Female	Pityriasis rosea	2 weeks
13	37	Male	Pityriasis rosea	6 weeks
14	25	Male	Pityriasis rosea	3 weeks
15	22	Male	Pityriasis rosea	5 weeks
16	41	Male	Pityriasis rosea	3 weeks
17	48	Female	Urticaria	2 weeks
18	41	Female	Urticaria	4 weeks
19	42	Male	Urticaria	2 weeks
20	36	Female	Urticaria	3 weeks
21	27	Female	Urticaria	1 week
22	29	Male	Urticaria	2 weeks
23	52	Female	Urticaria	6 weeks
24	36	Female	Telogen effluvium	12 weeks
25	38	Female	Telogen effluvium	16 weeks
26	26	Female	Telogen effluvium	10 weeks
27	31	Female	Telogen effluvium	14 weeks
28	42	Male	Telogen effluvium	10 weeks
29	43	Female	Telogen effluvium	8 weeks
30	43	Male	Alopecia areata	6 weeks
31	39	Female	Alopecia areata	8 weeks
32	33	Male	Herpes labialis	2 weeks
33	33	Male	Herpes labialis	2 weeks